New data support a change in management of the common eye disease glaucoma from eye drops, the current standard of care, to a ...

20 at AAO 2024, the 128th annual meeting of the American Academy of Ophthalmology, shows that laser treatment has an additional advantage: Glaucoma progressed 29% slower in patients treated with ...

About 3 million people in the United States have glaucoma, and it's the second leading cause of blindness worldwide, ...

Potential subjects were excluded if they had had previous glaucoma surgery or laser and also if intraocular surgery or additional SLT procedures were performed after the first treatment.

MOUNTAIN VIEW, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

Glaucoma is a group of eye diseases that cause slow ... They have been shown to be effective when taken regularly. Sometimes laser treatments or surgery are also recommended to slow the disease's ...

Santa Maria, California - ADV Vision is proud to announce the introduction of iDose® TR, a revolutionary treatment for glaucoma patients, making them the first in San Luis Obispo County to offer this ...

Iridex ( (IRIX) ) has released its Q3 earnings. Here is a breakdown of the information Iridex presented to its investors. Iridex Corporation is ...

Glaucoma occurs due to optic nerve damage. A common treatment is prescription eye drops. Although eye drops do not cure or reverse vision loss, they can help prevent optic nerve damage.

According to a new comprehensive report from The Insight Partners, the global Glaucoma Therapeutics Market is experiencing significant growth owing to ...